Carlyle Group's Marle International acquires Deloro Stellite

Equity financing for the acquisition was provided by The Carlyle Group.
Marle International was interested in acquiring ATS Sferic to increase its range of capabilities in the implant contract manufacturing business, and to expand its international market presence.

The Carlyle Group acquired Marle International in July 2009 from the founding Marle family and management, who retained a 20% stake in the company. Investment was made via Carlyle's €530m small buyout fund Carlyle Europe Technology Partners II. While under Carlyle ownership, Marle International has transitioned from a founder-run management to a new organisation and structure.

Company
ATS Sferic is a group of companies specialising in the casting and machining of knee and shoulder implants, as well as other orthopaedic instruments. The company's main site is located in Alès (south of France) and covers 5,800m2, while its headquarters are in the north. ATS Sferic has 120 employees in Alès and 93 working at HQ.

Debt
CIC Est, Société Générale and LCL provided the debt.

People
Andy Caffyn is CEO of Deloro Stellite. Antonio Gil is president of Marle International.  Partner Charlie Troup and Jason Lawford worked on the transaction for Duke Street Capital.

Advisers
Equity - Frieh Bouhénic (Legal), Deloitte Finance (Corporate finance) and Leonardo Midcap (M&A).

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Healthcare
• Expansion
• Now researching
• France
• Carlyle Group
• Acquisition finance